Safety evaluation of the food enzyme α‐amylase from the genetically modified Bacillus licheniformis strain DP‐Dzb52

Abstract The food enzyme α‐amylase (1,4‐α‐d‐glucan glucanohydrolase; EC 3.2.1.1) is produced with the genetically modified Bacillus licheniformis strain DP‐Dzb52 by Danisco US Inc. The production strain contains multiple copies of an antimicrobial resistance gene. However, based on the absence of viable cells and DNA from the production organism in the food enzyme, this is not considered to be a risk. The α‐amylase is intended to be used in starch processing for the production of glucose syrups, brewing processes and distilled alcohol production. Since residual amounts of the food enzyme are removed by the purification steps applied during the production of glucose syrups and distillation, no dietary exposure was calculated. Based on the maximum use levels recommended for the brewing processes and individual data from the EFSA Comprehensive European Food Consumption Database, dietary exposure to the enzyme–total organic solids (TOS) was estimated to be up to 0.145 TOS/kg body weight per day in European populations. The toxicity studies were carried out with another α‐amylase from B. licheniformis strain DP‐Dzb54, considered by the Panel as a suitable substitute. Toxicological tests indicated that there was no concern with respect to genotoxicity or systemic toxicity. A no observed adverse effect level was identified in rats which, compared with the dietary exposure, results in a margin of exposure of at least 750. A search for similarity of the amino acid sequence to known allergens was made and one match was found. The Panel considered that, under the intended conditions of use, the risk of allergic sensitisation and elicitation reactions can be excluded in distilled alcohol production and is considered low when the enzyme is used in starch processing and brewing. Based on the data provided, the Panel concluded that this food enzyme does not give rise to safety concerns under the intended conditions of use.

[1]  X. Baur,et al.  Allergic reaction after eating α‐amylase (Asp o 2)‐containing bread A case report , 1995 .

[2]  P. Cullinan,et al.  Clinical responses to ingested fungal α‐amylase and hemicellulase in persons sensitized to Aspergillus fumigatus? , 1997, Allergy.

[3]  L. Poulsen,et al.  Allergy assessment of foods or ingredients derived from biotechnology, gene-modified organisms, or novel foods. , 2004, Molecular nutrition & food research.

[4]  Test No. 408: Repeated Dose 90-Day Oral Toxicity Study in Rodents , 2018, OECD Guidelines for the Testing of Chemicals, Section 4.

[5]  S. E. Mainzer,et al.  Structural genes encoding the thermophilic alpha-amylases of Bacillus stearothermophilus and Bacillus licheniformis , 1986, Journal of bacteriology.

[6]  C. Leclercq,et al.  Guidance of EFSA: Use of the EFSA Comprehensive European Food Consumption Database in exposure assessment , 2011 .

[7]  M. Fernández-Rivas,et al.  Respiratory allergy to Aspergillus-derived enzymes in bakers' asthma. , 1992, The Journal of allergy and clinical immunology.

[8]  D. Moneret-vautrin,et al.  alpha-Amylase contained in bread can induce food allergy. , 1995, The Journal of allergy and clinical immunology.

[9]  S. Quirce,et al.  Occupational asthma caused by alpha-amylase inhalation: clinical and immunologic findings and bronchial response patterns. , 1992, The Journal of allergy and clinical immunology.

[10]  TG 442D.  OECD GUIDELINE FOR THE TESTING OF CHEMICALS In Vitro Skin Sensitisation: ARE-Nrf2 Luciferase Test Method , 2000 .

[11]  P. Cosmes,et al.  Bread eating induced oral angioedema due to alpha-amylase allergy. , 2004, Journal of investigational allergology & clinical immunology.

[12]  L. Belin,et al.  Clinical and immunological responses to occupational exposure to alpha-amylase in the baking industry. , 1991, British journal of industrial medicine.

[13]  A. Díaz‐Perales,et al.  Why can patients with baker's asthma tolerate wheat flour ingestion? Is wheat pollen allergy relevant? , 2009, Allergologia et immunopathologia.

[14]  J. Sastre,et al.  Glucoamylase: another fungal enzyme associated with baker's asthma. , 2002, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[15]  José Manuel Barat Baviera,et al.  Process‐specific technical data used in exposure assessment of food enzymes , 2021, EFSA journal. European Food Safety Authority.

[16]  H. Meyer,et al.  Allergy to Aspergillus-derived enzymes in the baking industry: identification of beta-xylosidase from Aspergillus niger as a new allergen (Asp n 14). , 1998, The Journal of allergy and clinical immunology.

[17]  H. Kuiper,et al.  Scientific Opinion on the assessment of allergenicity of GM plants andmicroorganisms and derived food and feed , 2010 .

[18]  P. Górski,et al.  [Baker's asthma]. , 1982, Pneumonologia polska.

[19]  José Manuel Barat Baviera,et al.  Characterisation of microorganisms used for the production of food enzymes , 2019, EFSA journal. European Food Safety Authority.